clindamycin hydrochloride
- Product NDC
- 69238-2121
- 11-digit product format
- 692382121
- Labeler code
- 69238
- Product ID
- 69238-2121_f118e287-5acc-4a8b-bcf0-01436de5bdf9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clindamycin hydrochloride
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA065194
- Marketing category
- ANDA
- Marketing start
- 2022-04-25
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| T20OQ1YN1W | CLINDAMYCIN HYDROCHLORIDE | 21462-39-5 | CLINDAMYCIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69238-2121-3 | 69238212103 | 3 BLISTER PACK in 1 CARTON (69238-2121-3) / 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (69238-2121-4) | 3 blister pack | 2022-04-25 | No | No | Historical |